Guerbet Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | Outperform |
9
|
$104.74 | $118.92 | 20.78% | 7 | $182.21B |
| MDT | Medtronic | Outperform |
11
|
$82.84 | $92.47 | 15.89% | 9 | $110.00B |
| BSX | Boston Scientific | Buy |
11
|
$73.69 | $70.14 | 11.28% | 6 | $108.34B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$235.67 | $284.47 | 17.75% | 8 | $68.11B |
| EW | Edwards Lifesciences Corp | Outperform |
11
|
$86.72 | $91.18 | 14.16% | 5 | $52.26B |
| 4543 | Terumo | Outperform |
18
|
¥5.63k | ¥4.97k | -9.46% | 0 | ¥3.76T |
| TFX | Teleflex Inc | Hold |
13
|
$203.93 | $263.46 | 18.18% | 2 | $9.64B |
| LNTH | Lantheus Holdings | Buy |
14
|
$76.02 | $91.75 | 31.54% | 1 | $5.26B |